The future of BNCT looks promising as ongoing research focuses on improving boron delivery agents, optimizing neutron sources, and refining treatment protocols. Advances in nanotechnology and molecular biology hold the potential to enhance the selectivity and efficacy of boron compounds. Additionally, the development of more accessible and compact neutron sources could make BNCT more widely available. Clinical trials and collaborative research efforts continue to explore new applications and improve outcomes for cancer patients.
